Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Best interests for who?

We will provide details on the litigation as circumstances permit. However, we ask our stockholders to appreciate that we remain under some contractual restrictions in regard to public disclosures pertaining to the MMP Portfolio, and we also wish to avoid any public sharing of information that could impair our litigation strategy. We regret having to take these measures, but we believe they are in the best long-term interests of Patriot, its stockholders, and our ownership in the MMP Portfolio.

From an August press release.

I am guessing this strategy is still in play. It's for our own good and long term benefit. They regret this but it is necessary. Like a dad telling the kid before he spanks him this is going to hurt me more than it hurts you. Sure it is dad just get it done already.

Share
New Message
Please login to post a reply